j uma's most recent trade in Clinitech Laboratory Ltd. was a Acquisition of 9,600 Equity Shares done at an average price of Rs. 35 . Disclosure was reported to the exchange on March 30, 2026 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
j uma's has made SAST transactions in Clinitech Laboratory Ltd. recently where a Acquisition of 8,400 shares done . Disclosure was reported to the exchange on Sept. 27, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinitech Laboratory | Mr. Jagdish Umakant Nayak | Promoter & Director | Acquisition | 30 Mar 2026 | 9,600 | 732,100 (32.08%) | 0.42% | 35 | 336,000 | 30 Mar 2026 30 Mar 2026 |
Insider Trading | Equity Shares | Market Purchase |
| Clinitech Laboratory | Mr. Jagdish Umakant Nayak | Promoter & Director | Acquisition | 27 Mar 2026 | 1,200 | 722,500 (31.65%) | 0.05% | 35 | 42,000 | 25 Mar 2026 25 Mar 2026 |
Insider Trading | Equity Shares | Market Purchase |
| Clinitech Laboratory | JAGDISH UMAKANT NAYAK | Promoter & Director | Acquisition | 20 Mar 2026 | 4,800 | 721,300 (31.60%) | 0.21% | 37.5 | 180,000 | 19 Mar 2026 20 Mar 2026 |
Insider Trading | Equity Shares | Market Purchase |
| Clinitech Laboratory | JAGDISH UMAKANT NAYAK | Promoter & Director | Acquisition | 18 Mar 2026 | 4,800 | 716,500 (31.39%) | 0.21% | 0 | 0 | 17 Mar 2026 18 Mar 2026 |
Insider Trading | Equity Shares | Market Purchase |
| Clinitech Laboratory | JAGDISH UMAKANT NAYAK | Promoter & Director | Acquisition | 13 Mar 2026 | 6,000 | 711,700 (31.18%) | 0.26% | 41.4 | 248,400 | 12 Mar 2026 13 Mar 2026 |
Insider Trading | Equity Shares | Market Purchase |
| Clinitech Laboratory | JAGDISH UMAKANT NAYAK | Promoter & Director | Acquisition | 12 Mar 2026 | 8,400 | 705,700 (30.92%) | 0.37% | 41.4 | 348,000 | 11 Mar 2026 11 Mar 2026 |
Insider Trading | Equity Shares | Market Purchase |
| Clinitech Laboratory | JAGDISH UMAKANT NAYAK | Promoter & Director | Acquisition | 10 Mar 2026 | 3,600 | 697,300 (30.55%) | 0.16% | 42.2 | 152,064 | 10 Mar 2026 10 Mar 2026 |
Insider Trading | Equity Shares | Market Purchase |
| Clinitech Laboratory | Jagdish Umakant Nayak | Promoter | Acquisition | 17 Oct 2025 | 8,400 | 693,700 (30.39%) | 0.37% | - | 26 Sep 2025 26 Sep 2025 |
SAST (29(2)) | - | Market | |
| Clinitech Laboratory | JAGDISH UMAKANT NAYAK | Promoter & Director | Acquisition | 27 Sep 2025 | 8,400 | 693,700 (30.39%) | 0.37% | 45.2 | 379,272 | 26 Sep 2025 26 Sep 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Clinitech Laboratory | Jagdish Umakant Nayak | Promoter | Acquisition | 18 Sep 2025 | 8,400 | 682,900 (29.92%) | 0.37% | - | 18 Aug 2025 18 Aug 2025 |
SAST (29(2)) | - | Market | |
| Clinitech Laboratory | JAGDISH UMAKANT NAYAK | Promoter & Director | Acquisition | 20 Aug 2025 | 8,400 | 682,900 (29.92%) | 0.37% | 44 | 369,600 | 18 Aug 2025 18 Aug 2025 |
Insider Trading | Equity Shares | Market Purchase |
| KM Sugar Mills | Umadevi Jhunjhunwala | Promoter | Disposal | 15 Jun 2021 | 11,000 | 2,551,717 (2.77%) | 0.01% | - | 11 Jun 2021 11 Jun 2021 |
SAST (29(2)) | - | Market | |
| KM Sugar Mills | UMADEVI JHUNJHUNWALA | Promoter | Disposal | 14 Jun 2021 | 11,000 | 2,551,717 (2.77%) | 0.01% | 36.9 | 405,900 | 11 Jun 2021 11 Jun 2021 |
Insider Trading | Equity Shares | Market Sale |